RCUS - Arcus Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RCUS is currently covered by 11 analysts with an average price target of $41.61. This is a potential upside of $18.65 (81.23%) from yesterday's end of day stock price of $22.96.

Arcus Biosciences's activity chart (see below) currently has 140 price targets and 136 ratings on display. The stock rating distribution of RCUS is 84% BUY and 16% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 31.88% with an average time for these price targets to be met of 209 days.

Highest price target for RCUS is $49, Lowest price target is $14, average price target is $30.33.

Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 02-Apr-2026. First documented stock forecast 09-Apr-2018.

Currently out of the existing stock ratings of RCUS, 21 are a BUY (84%), 4 are a HOLD (16%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Oct-2018

$41

$18.04 (78.57%)

$33

4 days ago
(02-Apr-2026)

3/14 (21.43%)

$18.04 (78.57%)

459

Buy Since 24-May-2019

$45

$22.04 (95.99%)

$44

1 months 1 days ago
(05-Mar-2026)

1/15 (6.67%)

$22.79 (102.61%)

328

Buy Since 09-Apr-2018

$49

$26.04 (113.41%)

$49

1 months 4 days ago
(02-Mar-2026)

4/10 (40%)

$25.06 (104.68%)

459

Buy Since 03-Jun-2025

$32

$9.04 (39.37%)

$32

1 months 4 days ago
(02-Mar-2026)

6/9 (66.67%)

$8.06 (33.67%)

280

Buy Since 11-Oct-2022

$20

$-2.96 (-12.89%)

$22

2 months 29 days ago
(08-Jan-2026)

4/9 (44.44%)

$-1.35 (-6.32%)

195

Show more analysts

Please expand the browser size to see the chart

What is RCUS (Arcus Biosciences) average time for price targets to be met?

On average it took 209 days on average for the stock forecasts to be realized with a an average price target met ratio 31.88

Which analyst has the current highest performing score on RCUS (Arcus Biosciences) with a proven track record?

GEOFFREY PORGES

Which analyst has the most public recommendations on RCUS (Arcus Biosciences)?

Geoffrey Porges works at LEERINK and has 8 price targets and 6 ratings on RCUS

Which analyst is the currently most bullish on RCUS (Arcus Biosciences)?

Kaveri Pohlman with highest potential upside - $47.04

Which analyst is the currently most reserved on RCUS (Arcus Biosciences)?

Peter Lawson with lowest potential downside - -$8.96

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?